Prospective feasibility study of ultrasonography-combined follow-up approach for post-radiotherapy hepatocellular carcinoma
Not Applicable
Recruiting
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000049003
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
1) Three months or longer duration between pretreatment radiological evaluation and SBRT 2) Apparent vascular invasion and/or metastasis 3) Unable to perform contrast-enhanced CT/MRI 4) Other diseases requiring more frequent contrast-enhanced CT/MRI 5) Considered not appropriate as a participant of this study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular markers correlate with tumor recurrence in JPRN-UMIN000049003 HCC post-radiotherapy US surveillance?
How does US-POSTR study compare ultrasonography-based monitoring to CT/MRI for HCC recurrence after radiotherapy?
Which biomarkers predict response to radiotherapy in hepatocellular carcinoma patients undergoing US follow-up per JPRN-UMIN000049003?
What are the safety profiles of combined radiotherapy and ultrasonography surveillance in HCC patients with cirrhosis?
How does JPRN-UMIN000049003 integrate US with serum AFP levels for HCC recurrence detection post-radiotherapy?